The first Nuvectis Pharma trade was made in Q2 2023.
Since then Jim Simons bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q3 2025 and Q4 2025.
Avg closing price
Price range
Sold -42.8k shares
Q4 2025
Avg closing price
$6.51
Price range
$5.65
-
$8.26
Sold 0.5% shares (-200 shares)
Q3 2025
Avg closing price
$6.88
Price range
$5.92
-
$8.28
New holding (+43k shares)
Q2 2025
Avg closing price
$9.06
Price range
$7.47
-
$10.96
Sold -15.8k shares
Q4 2024
Avg closing price
$6.21
Price range
$4.52
-
$10.98
Sold 78.8% shares (-58.7k shares)
Q3 2024
Avg closing price
$6.58
Price range
$6.16
-
$7.23
Increased shares by 20.7% (+12.8k shares)
Q2 2024
Avg closing price
$6.80
Price range
$5.98
-
$8.25
Increased shares by 19.1% (+9.9k shares)
Q1 2024
Avg closing price
$8.50
Price range
$6.69
-
$11.00
Increased shares by 103.9% (+26.4k shares)
Q4 2023